Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2005 participants.
Also called NCT03108456
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,005 participants
- Registry
-
NCT03108456
-
- Other papers using this trial's data
- Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy
- Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03108456. Randomized; no masking; primary purpose treatment. Start 2017-03-27 (actual); primary completion 2024-06-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
- Acronym
- ECLIPSE
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Heart Disease
- Condition
- Non ST Segment Elevation Myocardial Infarction
- Intervention (Device)
- Orbital Atherectomy
- Intervention (Device)
- Balloon
- Lead sponsor
- Abbott Medical Devices
- Collaborator
- Cardiovascular Research Foundation, New York
Record details
- Record id
cardio:ct-nct03108456- Content hash
6e92d226773d7f1442b20e89f0e919522571ad564a2f4d7d6babfcfdf8554b3b